Intensive insulin therapy: a personal and historical perspective

Area of Science:

• Endocrinology and Metabolism
• Diabetes Management

Background:

• Intensive therapy for Type I diabetes involves the patient as a key partner in daily management.
• Technological advancements in the late 1970s were crucial for developing intensive therapy strategies.

Purpose of the Study:

• To highlight the pivotal role of self-monitoring of blood glucose (SMBG) in the intensive therapy revolution.
• To discuss how technological innovations facilitated the development and research of intensive diabetes management.

Main Methods:

• The study reviews the impact of key technological developments, including SMBG devices and glycated hemoglobin measurements.
• It also considers the influence of continuous subcutaneous insulin infusion (CSII) on insulin regimen development.

Main Results:

• Self-monitoring of blood glucose (SMBG), spurred by finger-pricking devices, was a major catalyst for intensive diabetes therapy.
• Glycated hemoglobin measurements provided quantitative assessment of glycemic control, enhancing therapy evaluation.
• Continuous subcutaneous insulin infusion (CSII) advanced the understanding of insulin regimens.

Conclusions:

• Technological advancements have collectively enabled intensive therapy as a primary diabetes management strategy.
• These innovations also facilitate research protocols to assess the long-term impact of intensive therapy on diabetes complications.